| |
| |
| Exchange: |
Nasdaq Small Cap |
| Security
Type: |
Common |
| Shares
Out: |
52,373,000 |
| Market
Cap: |
2.64(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$30.85 - $52.9 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Laboratories & Research |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 474 |
| Guru Rank Value : 3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Vericel is a biopharmaceutical company providing cell therapies for the sports medicine and severe burn care markets. Co.'s products include: MACI®, which is an autologous cellularized scaffold product indicated for the repair of symptomatic, full-thickness cartilage defects of the knee with or without bone involvement in adults; and Epicel®, which is a permanent skin replacement for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns comprising greater than or equal to 30% of total body surface area. Co. also holds a license for North American rights to NexoBrid®, a registration-stage biological orphan product for debridement of severe thermal burns.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
134,016 |
288,272 |
298,234 |
338,833 |
| Total Sell Value |
$6,182,554 |
$12,249,320 |
$12,614,520 |
$13,716,779 |
| Total People Sold |
5 |
6 |
7 |
7 |
| Total Sell Transactions |
11 |
28 |
33 |
36 |
| End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Durbin Scott |
Chief Financial Officer |
• – – |
2011-03-04 |
4 |
B |
$2.17 |
$29,375 |
D/D |
13,537 |
30,000 |
2.74 |
- |
|
| Mayleben Timothy M |
CEO and President |
• • – |
2011-03-03 |
4 |
B |
$2.14 |
$31,681 |
D/D |
14,832 |
103,000 |
2.81 |
- |
|
| Mayleben Timothy M |
CEO and President |
• • – |
2011-03-02 |
4 |
B |
$2.09 |
$13,683 |
D/D |
6,550 |
88,168 |
2.81 |
- |
|
| Mayleben Timothy M |
CEO & President |
• • – |
2010-11-24 |
4 |
B |
$2.20 |
$26,340 |
D/D |
12,000 |
81,618 |
2.81 |
- |
|
| Mayleben Timothy M |
CEO and President |
• • – |
2010-08-30 |
4 |
B |
$1.45 |
$24,940 |
D/D |
17,200 |
69,618 |
2.81 |
- |
|
| Durbin Scott |
CFO |
• – – |
2010-08-26 |
4 |
B |
$1.43 |
$23,842 |
D/D |
16,463 |
16,463 |
2.74 |
- |
|
| Mayleben Timothy M |
CEO, President, CFO & Director |
• • – |
2010-05-21 |
4 |
B |
$1.42 |
$24,992 |
D/D |
17,600 |
52,418 |
2.81 |
- |
|
| Dunbar George W Jr |
Director |
– • – |
2010-03-10 |
4 |
B |
$1.56 |
$14,013 |
I/I |
9,000 |
12,750 |
2.1 |
- |
|
| Mayleben Timothy M |
CEO, President, CFO & Director |
• • – |
2010-03-08 |
4 |
B |
$1.47 |
$24,623 |
D/D |
16,750 |
34,818 |
2.81 |
- |
|
| Mayleben Timothy M |
CEO, President, CFO & Director |
• • – |
2010-03-05 |
4 |
B |
$1.45 |
$24,983 |
D/D |
17,206 |
18,068 |
2.81 |
- |
|
| Simms Nelson M |
Director |
– • – |
2008-10-17 |
4 |
A |
$0.00 |
$0 |
D/D |
155,200 |
225,000 |
|
- |
|
| Simms Nelson M |
Director |
– • – |
2008-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
64,300 |
69,800 |
|
- |
|
| Dunbar George W Jr |
President & CEO |
• • – |
2007-11-12 |
4 |
B |
$0.90 |
$18,000 |
D/D |
20,000 |
30,000 |
2.81 |
- |
|
| Brennan Gerald Jr |
VP Admin. and Finance, CFO |
• – – |
2007-11-12 |
4 |
B |
$0.94 |
$18,800 |
D/D |
20,000 |
30,000 |
2.74 |
- |
|
| Simms Nelson M |
Director |
– • – |
2007-11-12 |
4 |
B |
$0.90 |
$9,000 |
I/I |
10,000 |
10,000 |
2.1 |
- |
|
| Sudovar Stephen |
Director |
– • – |
2007-09-14 |
4 |
B |
$1.12 |
$11,200 |
D/D |
10,000 |
26,900 |
2.39 |
- |
|
| Dunbar George W Jr |
President & CEO |
• • – |
2007-05-11 |
4 |
B |
$1.45 |
$14,492 |
D/D |
10,000 |
10,000 |
2.81 |
- |
|
| Armstrong R Douglas Phd |
Director |
– • – |
2006-07-17 |
4 |
A |
$0.00 |
$0 |
D/D |
3,300 |
577,063 |
|
- |
|
| Armstrong R Douglas Phd |
Chairman and CEO |
• – – |
2006-06-06 |
4 |
B |
$1.26 |
$10,080 |
D/D |
8,000 |
573,763 |
2.74 |
- |
|
| Sudovar Stephen |
Director |
– • – |
2006-05-18 |
4 |
B |
$1.37 |
$13,700 |
D/D |
10,000 |
16,900 |
2.39 |
- |
|
| Hock Janet Mary |
VP Global Research & CSO |
• – – |
2006-05-12 |
4 |
S |
$1.35 |
$50,441 |
D/D |
(37,139) |
37,136 |
|
- |
|
| Hock Janet Mary |
VP Global Research & CSO |
• – – |
2006-05-12 |
4 |
OE |
$1.05 |
$49,219 |
D/D |
46,875 |
74,275 |
|
- |
|
| Brennan Gerald Jr |
VP Admin. & Finance, CFO |
• – – |
2006-02-16 |
4 |
B |
$1.75 |
$17,500 |
D/D |
10,000 |
10,000 |
2.74 |
- |
|
| Armstrong R Douglas Phd |
CEO and Chairman of the Board |
• – – |
2006-02-13 |
4 |
B |
$1.67 |
$5,010 |
D/D |
3,000 |
565,763 |
2.74 |
- |
|
| Simms Nelson M |
Director |
– • – |
2006-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
5,500 |
5,500 |
|
- |
|
401 Records found
|
|
Page 14 of 17 |
|
|
1.20 (2.33%) 
